✦ LIBER ✦

A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry

✍ Scribed by Greenberg, J. D.; Reed, G.; Decktor, D.; Harrold, L.; Furst, D.; Gibofsky, A.; DeHoratius, R.; Kishimoto, M.; Kremer, J. M.

Book ID: 119970262
Publisher: BMJ Publishing Group
Year: 2012
Tongue: English
Weight: 200 KB
Volume: 71
Category: Article
ISSN: 0003-4967
DOI: 10.1136/annrheumdis-2011-150573

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disability outcomes and dose escalation

Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study

✍ Schabert, V.F.; Bruce, B.; Ferrufino, C.F.; Globe, D.R.; Harrison, D.J.; Lingala 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 234 KB

Comparative effectiveness and survival o

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

✍ Flouri, Irini; Markatseli, Theodora E.; Voulgari, Paraskevi V.; Boki, Kyriaki A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 696 KB

Safety and effectiveness of switching fr

Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study

✍ Koike, Takao; Harigai, Masayoshi; Inokuma, Shigeko; Ishiguro, Naoki; Ryu, Junnos 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 272 KB

Long-term anti-TNF therapy and the risk

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

✍ Atzeni, Fabiola; Sarzi-Puttini, Piercarlo; Botsios, Costantino; Carletto, Antoni 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Clinical and radiographic results from a

Clinical and radiographic results from a 2-year comparison of once-weekly versus twice-weekly administration of etanercept in biologics-naive patients with rheumatoid arthritis

✍ Takahiko Wada,Yonsu Son,Yoshiro Ozaki,Shosaku Nomura… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 376 KB

Direct comparison of treatment responses

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

✍ Merete Lund Hetland; Ib Jarle Christensen; Ulrik Tarp; Lene Dreyer; Annette Hans 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views